Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims
Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the biopharmaceutical company and two former executives for misleading claims about the results of Alzheimer's clinical trials.
SEC Announces $40 Mln Settlement With Cassava Sciences Over Misleading Alzheimer's Trial Statements
The U.S. Securities and Exchange Commission announced Cassava Sciences Inc. (SAVA), its founder and former CEO, Remi Barbier, and its
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.
US charges Cassava Sciences, two former executives for misleading claims about Alzheimer’s clinical trial
The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former executives for misleading claims about the results of Alzheimer’s clinical trials.
Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines
Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the Alzheimer's drug simufilam, and agreed to pay fines.
Alzheimer's treatment that uses Benfotiamine will be tested in large clinical trial
Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...
LifeVantage Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss*
Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...
Medical Xpress on MSN3d
Clinical trial supports adding ruxolitinib to tyrosine kinase inhibitors for chronic myeloid leukemia
Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase ...
Lupus Foundation of America15h
UPDATE: Positive Phase III Clinical Trial Results Announced for Gazyva for the Treatment of Lupus Nephritis
Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, ...
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial ...
Clinical trial: Preventing heart injury caused by anticancer drugs
The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...
UC San Francisco8d
Clinical Trial Could Move the Needle in Traumatic Brain Injury
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical ...
SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial
The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and ...
clinicaltrialsarena9h
ProJenX and Unlearn partner to use AI-generated digital twins in ALS trial
ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...